NCT05127096 - Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

December 30, 2022

Conditions

Colorectal Cancer Screening

Interventions

DIAGNOSTIC_TEST

FirstSight blood test

FirstSight blood test for colorectal cancer screening

Trial Locations (15)

17011

RECRUITING

CellMax Site M, Camp Hill

33067

RECRUITING

CellMax Site D, Coral Springs

RECRUITING

CellMax Site G, Coral Springs

33125

RECRUITING

CellMax Site C, Miami

33134

RECRUITING

CellMax Site P, Coral Gables

35801

ACTIVE_NOT_RECRUITING

CellMax Site A, Huntsville

44060

RECRUITING

CellMax Site N, Mentor

70006

RECRUITING

CellMax Site B, Metairie

77084

RECRUITING

CellMax Site K, Houston

77504

RECRUITING

CellMax Site F, Pasadena

78212

RECRUITING

CellMax Site H, San Antonio

78539

RECRUITING

CellMax Site E, McAllen

91910

RECRUITING

CellMax Site O, Chula Vista

92780

RECRUITING

CellMax Site J, Tustin

93534

RECRUITING

CellMax Site L, Lancaster